What Pacira BioSciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 17 |
| Total trades | 3 | 50 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 6,000 | 592,225 |
| Disposed | 9,040 | 219,416 |
| Net activity | −3,040 | +372,809 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Riker Lauren Bullaro | Senior Vice President, Finance | Oct 08 | Disclosed 10b5-1 sale · S | −6,000 | $36.32 | −$218K | 62,284 |
| Riker Lauren Bullaro | Senior Vice President, Finance | Oct 08 | Exercise / conversion · M | +6,000 | $32.35 | +$194K | 68,284 |
| Slonin Jonathan | Chief Medical Officer | Aug 17 | Open-market sale · S | −3,040 | $23.23 | −$70.6K | 216,384 |
| Riker Lauren Bullaro | Senior Vice President, Finance | Jun 11 | Disclosed 10b5-1 sale · S | −6,115 | $23.50 | −$144K | 62,284 |
| Brege Laura | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 30,120 |
| Yang Michael J. | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 19,798 |
| Bigal Marcelo | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 17,798 |
| Young Alethia | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 17,798 |
| Christie Christopher | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 23,059 |
| Froimson Mark | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 26,541 |
| Hirawat Samit | Director | Jun 10 | Grant / award · A | +6,405 | — | — | 6,405 |
| Dunker Kristen Marie | Chief Administrative Officer | Jun 04 | Disclosed 10b5-1 sale · S | −10,259 | $22.27 | −$228K | 167,062 |
| Dunker Kristen Marie | Chief Administrative Officer | Jun 03 | Withheld — tax / exercise cost · F | −8,528 | $22.32 | −$190K | 177,321 |
| Slonin Jonathan | Chief Medical Officer | Jun 03 | Withheld — tax / exercise cost · F | −4,728 | $22.32 | −$106K | 218,912 |
| Riker Lauren Bullaro | Senior Vice President, Finance | Jun 03 | Withheld — tax / exercise cost · F | −3,187 | $22.32 | −$71.1K | 68,399 |
| Cross Shawn | Chief Financial Officer | Apr 23 | Disclosed 10b5-1 sale · S | −12,941 | $25.16 | −$326K | 105,341 |
| Cross Shawn | Chief Financial Officer | Apr 23 | Exercise / conversion · M | +12,941 | $16.45 | +$213K | 118,282 |
| Cross Shawn | Chief Financial Officer | Apr 22 | Disclosed 10b5-1 sale · S | −1,500 | $25.01 | −$37.5K | 105,341 |
| Cross Shawn | Chief Financial Officer | Apr 22 | Exercise / conversion · M | +1,500 | $16.45 | +$24.7K | 106,841 |
| Cross Shawn | Chief Financial Officer | Apr 21 | Disclosed 10b5-1 sale · S | −2,845 | $25.01 | −$71.2K | 105,341 |
Loading...
